Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Falco Announces Extension of Its Senior Debts
-
BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
-
September 2025 Quarterly Activities Report
-
Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award
-
Mesa Air Group enters into an Amendment to its Loan Agreement with the United States Treasury and Provides Update to its Pending Merger with Republic Airways
-
Perspective Therapeutics to Participate in Upcoming November Conferences
-
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorec
-
Upstream Bio to Participate in Upcoming November Investor Conferences
-
Castellum, Inc. Announces the Award of a $66.2 million Full and Open Contract to its SSI Subsidiary
-
AirSculpt Technologies Announces Third Quarter Fiscal 2025 Earnings Release Date and Conference Call
-
BNP Paribas Primary New Issues: POST-STAB Notice: No Stab - PCC GLOBAL PLC
-
PCCA UK Leadership Announcement
-
NANO Nuclear Senior Executives to Present at Upcoming November Nuclear Industry Conferences Including ADIPEC 2025, the World’s Largest Energy Conference
-
Carlyle Credit Income Fund Announces Private Placement of Convertible Preferred Shares
-
LyondellBasell reports third quarter 2025 earnings
-
Carlyle Secured Lending, Inc. Announces Intent to Redeem All Outstanding 8.20% Notes Due 2028
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
Scandinavian Tobacco Group A/S: New employee-elected Board member
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
Form 8.3 - Unite Group plc
-
Cenovus announces third-quarter 2025 results
-
Immuron Announces Clinical Trial Update
-
Hepsiburada to Announce Third Quarter 2025 Results on November 5, 2025
-
Karolinska Development’s portfolio company BOOST Pharma presents positive long-term data for its cell-based treatment of Osteogenesis imperfecta
-
AS Tallinna Vesi held an investor conference webinar to introduce the results of the third quarter of 2025
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
Result of the auction of treasury bills on 31 October 2025
-
Form 8.3 - [IDOX PLC - 30 10 2025] - (CGWL)
-
"Beautiful China: The Magnificent Great Wall across Beijing, Tianjin and Hebei," has been officially launched
-
"Beautiful China: The Magnificent Great Wall across Beijing, Tianjin and Hebei," has been officially launched
-
Aurora Mobile Partners with Tuniu to Enhance Travel Experience with JPush Intelligent Messaging
-
Magna Announces Third Quarter 2025 Results
-
Municipality Finance’s capital adequacy remains well above the ECB minimum requirements
-
VCI Global Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
FLSmidth closes the sale of the Cement business to Pacific Avenue Capital Partners
-
Festi hf.: Presentation of Q3 2025 results
-
Realkredit Danmark will change the refinancing term on new loans
-
Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox
-
Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong
-
SilentSwap Launches V2, Enabling Seamless Non-Custodial Cross-Chain Privacy for Web3 Transactions
-
SilentSwap Launches V2, Enabling Seamless Non-Custodial Cross-Chain Privacy for Web3 Transactions
-
Utenos Trikotažas Grows Sales by One-Third While Maintaining Profitability
-
FanttikRide Brings Joy to a Child With a Customized Left-Pedal Wiggle Car
-
SREP capital requirements set for AB Artea bankas
-
Sidetrade and NX Partners form Alliance to Strengthen CFO Resilience in Benelux and Switzerland
-
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
-
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2025
-
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2025
-
Announcement of the net asset value of INVL Technology as of 30 September 2025
-
INVL Technology results for 9 months of 2025
